Selecta Biosciences, Inc.

SELB

1 Followers
$0.88 -8.00% -$0.08
N/A
Upcoming Earnings
 
Market Cap.
 
P/E
Loading...

My Notes

Začít psát

Profile

Selecta Biosciences, Inc. (SELB) is a biotechnology company focused on developing innovative therapeutic products and drugs based on immunomodulation technology. The company employs nanotechnology and immunology platforms to create medicines that can influence the immune system to treat various diseases. Selecta Biosciences is dedicated to developing therapies for autoimmune diseases, allergies, and other health conditions. Their innovative approach to treatment has garnered attention within the medical realm. Shares of Selecta Biosciences, Inc. (SELB) can be an attractive choice for investors tracking advancements in biotechnology and novel therapeutic methods.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios


Or use email and password
Already a member? Log in

Create Bulios profile

Continue with

Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools

Menu StockBot
Tracker
Upgrade